MADISON, Wis.--(BUSINESS WIRE)--BioForward Wisconsin, the collective voice of Wisconsins robust and comprehensive biohealth cluster, representing more than 220 member organizations, has announced the winners of the sixth annual Wisconsin Biohealth Awards. These awards showcase leadership and innovation in the Wisconsin biohealth industry and specifically recognize scientific and business successes that have brought Wisconsin to be leaders in integrated health solutions
DUBLIN, Sept. 3, 2020 /PRNewswire/ -- The "Global Human Microbiome Immunology Therapeutics Market & Clinical Trial Insight 2025" clinical trials has been added to ResearchAndMarkets.com's offering. The scale and scope of microbiome research activity has now become one of the fastest growing areas in biology.
40 experts delivered keynote speeches or participated in discussions during the online event, which attracted participants from more than 300 hospitals/institutes and over 40,000 views. Prof.
Visit the News Hub Gene in fruit flies, worms, zebrafish, mice and people may help explain some fertility issues Researchers at Washington University School of Medicine in St. Louis have identified a gene that plays an important role in fertility across multiple species. Pictured is a normal fruit fly ovary (left) and a fruit fly ovary with this gene dialed down (right).
LONDON--(BUSINESS WIRE)--The stem cell therapy market is expected to register a CAGR of almost 7% during 2020-2024, as per the latest research report by Technavio. The report offers a detailed analysis of the impact of COVID-19 pandemic on the market in optimistic, probable, and pessimistic forecast scenarios.
Most industries today are under pressure to switch to more ethical and sustainable animal-free alternatives, and now the trend is coming to stem cell labs. As stem cell applications accelerate towards the clinic, novel drug discovery platforms are rapidly scaled, and new transformative stem cell-based technologies such as cultured meat arise, there is a drive to switch to animal-free cell culture media. This move is essential to facilitate future regulatory approval for advanced therapies, and enable pharma and biotech companies to ethically, reproducibly and cost-effectively scale stem cell-based innovations.Most stem cell scientists today use recombinant growth factor and cytokine proteins in their chemically-defined media to supply their cultures with the necessary biological signals required for maintenance of pluripotency, cell proliferation and differentiation into specific cell lineages.
Share this Article You are free to share this article under the Attribution 4.0 International license. Researchers have found a way, in mice and human tissue, to regenerate the cartilage that eases movement between bones. Loss of this slippery and shock-absorbing tissue layer, called articular cartilage, is responsible for many cases of joint pain and arthritis, which afflicts more than 55 million Americans.
Technology is at our fingertips. Think of all the health monitors or wearable fitness trackers that people are using today.
Auxolytic has developed a nutrient-based safety-switch for cell therapies that doesnt rely on introducing transgenes. The process, auxotrophy, uses the engineered inability of an organism to synthesize a compound required for its survival to allow physicians to turn off a gene therapy if serious side effects develop. The work currently is in preclinical phases, in humanized cells in mice, and appears promising
DUBLIN, Aug. 19, 2020 /PRNewswire/ -- The "3D Cell Cultures: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The report includes: Whether the discussion is about stem cells, tissue engineering, or microphysiological systems, their vital role in drug discovery, toxicology, and other areas leading to new product development, 3D cell culture is becoming the environment that will increasingly define the basis for future advances.
Recent Comments